Jpmorgan Chase & CO Schedule 13G passive stakes

JPMorgan Chase & Co. has disclosed an increased beneficial ownership of 7.3% in Trane Technologies PLC, holding over 16.4 million ordinary shares.

JPMorgan Chase & Co. has reported an increased beneficial ownership of 8.7% in Baker Hughes Company's Class A Common Stock.

JPMorgan Chase & Co. has disclosed a 9.1% beneficial ownership stake in Natera, Inc., holding over 12.8 million shares as of December 31, 2025.

JPMorgan Chase & Co. has filed an amendment to its Schedule 13G, reporting an 8.0% beneficial ownership in NXP Semiconductors N.V. as of December 31, 2025.

JPMorgan Chase & Co. reported an 8.7% beneficial ownership stake in Silgan Holdings Inc. common stock, totaling 9,274,096 shares.

JPMorgan Chase & Co. has disclosed an increased beneficial ownership of 6.0% in Twilio Inc.'s Class A Common Stock as of December 31, 2025.

JPMorgan Chase & Co. reported an increased beneficial ownership of 6.0% in Utz Brands, Inc. Class A Common Stock as of December 31, 2025.

JPMorgan Chase & Co. has reported a 12.1% beneficial ownership stake in Vicor Corporation, holding over 4 million shares as of December 31, 2025.

JPMorgan Chase & Co. has reported an increased beneficial ownership of 9.1% in Warby Parker Inc.'s Class A Common Stock as of December 31, 2025.

JPMorgan Chase & Co. reported a 7.2% beneficial ownership stake in Yum! Brands, Inc., holding over 20 million shares as of December 31, 2025.

JPMorgan Chase & Co. has reported a 7.7% beneficial ownership stake in Ciena Corporation, holding over 10.8 million shares of common stock.

JPMorgan Chase & Co. has reported a 5.0% beneficial ownership stake in Entergy Corporation's common stock as of December 31, 2025.

JPMorgan Chase & Co. has filed a Schedule 13G indicating a future beneficial ownership of 5.4% of Kontoor Brands, Inc. common stock by December 31, 2025.

JPMorgan Chase & Co. has disclosed a 6.3% beneficial ownership stake in LB Pharmaceuticals Inc., holding over 1.6 million shares of common stock.

JPMorgan Chase & Co. has reported a 5.9% beneficial ownership stake in Lemonade, Inc., holding over 4.4 million shares.

JPMorgan Chase & Co. has reported a 5.2% beneficial ownership stake in Neurocrine Biosciences, Inc. as of December 31, 2025, held in the ordinary course of business.

JPMorgan Chase & Co. has reported a 5.1% beneficial ownership stake in SoFi Technologies, Inc. as of December 31, 2025.

JPMorgan Chase & Co. has reported a 5.2% beneficial ownership stake in The Macerich Company, totaling 13,381,853 shares of common stock.

JPMorgan Chase & Co. has reported a 5.9% beneficial ownership stake in Ventas, Inc., holding over 28 million shares as a passive investor.

JPMorgan Chase & Co. reported a 5.5% beneficial ownership stake in Grupo Televisa, holding over 140 million CPOs/GDSs as of December 31, 2025.

JPMorgan Chase & Co. has reported a 5.1% beneficial ownership in DraftKings Inc.'s Class A Common Stock.

JPMorgan Chase & Co. has reported a 6.4% beneficial ownership stake in DocuSign, Inc., holding over 13.7 million shares.

JPMorgan Chase & Co. has reported a 5.0% beneficial ownership stake in Lamb Weston Holdings, Inc., totaling 7,070,793 shares of common stock.

JPMorgan Chase & Co. has filed an amended Schedule 13G, disclosing a 4.0% beneficial ownership stake in Radiopharm Theranostics Limited as of December 31, 2025.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a beneficial ownership of 4.7% in Sibanye Stillwater Limited as of December 31, 2025.

JPMorgan Chase & Co. has reported a 14.0% beneficial ownership stake in Andersen Group Inc.'s Class A Common Stock as of December 31, 2025.

JPMorgan Chase & Co. has disclosed a 7.2% passive ownership stake in Flowco Holdings Inc.'s Class A common stock, effective November 28, 2025.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting a 4.2% beneficial ownership stake in Host Hotels & Resorts, Inc.

JPMorgan Chase & Co. has filed an amendment to its Schedule 13G, disclosing a 4.1% beneficial ownership stake in Almacenes Exito S.A.

JPMorgan Chase & Co. has disclosed a 4.1% beneficial ownership stake in Ameriprise Financial, Inc., holding 3,866,962 common shares.